JP2003533533A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003533533A5 JP2003533533A5 JP2001584289A JP2001584289A JP2003533533A5 JP 2003533533 A5 JP2003533533 A5 JP 2003533533A5 JP 2001584289 A JP2001584289 A JP 2001584289A JP 2001584289 A JP2001584289 A JP 2001584289A JP 2003533533 A5 JP2003533533 A5 JP 2003533533A5
- Authority
- JP
- Japan
- Prior art keywords
- embedded image
- formula
- prot
- lactone
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 238000006929 Pictet-Spengler synthesis reaction Methods 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- -1 t-butyloxycarbonyl Chemical group 0.000 description 3
- 0 CC(Oc1c([C@](C([C@]2N([C@]3C4)[C@@]4(*)c(cc4C)c2c(O)c4OC)N([C@]2COC4=O)[C@]3C#N)SCC4=O)c2c2OCOc2c1C)=O Chemical compound CC(Oc1c([C@](C([C@]2N([C@]3C4)[C@@]4(*)c(cc4C)c2c(O)c4OC)N([C@]2COC4=O)[C@]3C#N)SCC4=O)c2c2OCOc2c1C)=O 0.000 description 2
- WJXQFVMTIGJBFX-UHFFFAOYSA-N COc(ccc(CCN)c1)c1O Chemical compound COc(ccc(CCN)c1)c1O WJXQFVMTIGJBFX-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000005891 transamination reaction Methods 0.000 description 2
- HKOHNXFWPSFDSX-NWWCCKEQSA-N C[C@]1(C[C@H]2[C@H](C#N)N([C@@H](COC3=O)c4c5OCOc5c(C)c(OC(C)=O)c44)C5[C@@H]4SCC3=O)N2[C@@H]5c2c1cc(C)c(OC)c2O Chemical compound C[C@]1(C[C@H]2[C@H](C#N)N([C@@H](COC3=O)c4c5OCOc5c(C)c(OC(C)=O)c44)C5[C@@H]4SCC3=O)N2[C@@H]5c2c1cc(C)c(OC)c2O HKOHNXFWPSFDSX-NWWCCKEQSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
Description
【特許請求の範囲】
【請求項1】 以下のスキーム:
【化1】
[式中、ProtNHはアミノ保護基であり、ProtOHはヒドロキシ保護基である]
に従って、単一の工程で両者の保護基を除去することによって、式(A)の化合物を脱保護して式(35)のα-アミンラクトンを得る工程を含む、エクチナサイジン化合物の製造における方法工程。
【請求項2】 Prot NH がt-ブチルオキシカルボニルであり、Prot OH がメトキシメチルである、請求項1記載の方法。
【請求項3】 Prot NH がt-ブチルオキシカルボニルであり、Prot OH がメトキシエトキシメチルである、請求項1記載の方法。
【請求項4】 式(35)のα-アミンラクトンを、下式:
【化2】
のアミノ基転移によって、式(36)の対応するα-ケトラクトンに酸化する更なる工程を含む、請求項1記載の方法。
【請求項5】 式(36)のα-ケトラクトンから、下式:
【化3】
のPictet-Spengler反応によって、スピロテトラヒドロイソキノリン化合物Et770を立体特異的に形成する更なる工程を含む、請求項4記載の方法。
【請求項6】 下式:
【化4】
のEt770のC-21でのニトリルのヒドロキシによる置換によりEt743を得る更なる工程を含む、請求項5に記載の方法。
【請求項7】 式(35)のα-アミンラクトンを、下式:
【化5】
のアミノ基転移によって、式(36)の対応するα-ケトラクトンに酸化することによる、エクチナサイジン化合物の製造における方法工程。
【請求項8】 式(36)のα-ケトラクトンから、下式:
【化6】
のPictet-Spengler反応によって、スピロテトラヒドロイソキノリン化合物Et770を立体特異的に形成する更なる工程を含む、請求項7記載の方法。
【請求項9】 下式:
【化7】
のEt770のC-21でのニトリルのヒドロキシによる置換によりEt743を得る更なる工程を含む、請求項8に記載の方法。
【請求項10】 式(36)のα-ケトラクトンから、下式:
【化8】
のPictet-Spengler反応によって、スピロテトラヒドロイソキノリン化合物Et770を立体特異的に形成することによる、エクチナサイジン化合物の製造における方法工程。
【請求項11】 下式:
【化9】
のEt770のC-21でのニトリルのヒドロキシによる置換によりEt743を得る更なる工程を含む、請求項10に記載の方法。
【請求項12】 中間体が式(35):
【化10】
である、エクチナサイジン化合物の合成のための中間体。
【請求項13】 中間体が式(36):
【化11】
である、エクチナサイジン化合物の合成のための中間体。
[Claims]
1. The following scheme:
Embedded image
[Where ProtNHIs an amino protecting group, ProtOHIs a hydroxy protecting group]
Remove both protecting groups in a single step according toDeprotecting the compound of formula (A) to obtain an α-amine lactone of formula (35)Method steps in the production of an ectinacydin compound.
(2) Prot NH Is t-butyloxycarbonyl, and Prot OH 2. The method of claim 1, wherein is methoxymethyl.
(3) Prot NH Is t-butyloxycarbonyl, and Prot OH 2. The method of claim 1, wherein is methoxyethoxymethyl.
(4) The α-amine lactone of the formula (35) is converted into the following formula:
Embedded image
The process according to claim 1, comprising the further step of oxidizing to the corresponding α-keto lactone of formula (36) by transamination of
(5) From α-keto lactone of equation (36),
Embedded image
The method according to claim 4, further comprising a step of stereospecifically forming a spirotetrahydroisoquinoline compound Et770 by a Pictet-Spengler reaction of the above.
6. The following formula:
Embedded image
6. A process according to claim 5, comprising the further step of substituting the nitrile at C-21 of Et770 with hydroxy to give Et743.
7. The α-amine lactone of the formula (35) is converted into the following formula:
Embedded image
Process steps in the preparation of ectinacydin compounds by oxidation to the corresponding α-keto lactone of formula (36) by transamination of
8. From α-keto lactone of equation (36),
Embedded image
The method according to claim 7, further comprising a step of stereospecifically forming a spirotetrahydroisoquinoline compound Et770 by a Pictet-Spengler reaction of the above.
9. The following formula:
Embedded image
9. The method of claim 8, comprising the further step of substituting the nitrile at C-21 of Et770 with hydroxy to give Et743.
10. From α-keto lactone of equation (36),
Embedded image
A method step in the production of an ectinacydin compound by stereospecifically forming a spirotetrahydroisoquinoline compound Et770 by the Pictet-Spengler reaction.
11. The following formula:
Embedded image
11. The method of claim 10, comprising the further step of displacing the nitrile at C-21 of Et770 with hydroxy to give Et743.
12. The intermediate is of formula (35):
Embedded image
An intermediate for the synthesis of ectinacydin compounds.
Claim 13 The intermediate is of formula (36):
Embedded image
An intermediate for the synthesis of ectinacydin compounds.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB2000/001852 WO2000069862A2 (en) | 1999-05-14 | 2000-05-15 | Hemisynthetic method and intermediates thereof |
GB00/01852 | 2000-05-15 | ||
GBPCT/GB00/01852 | 2000-05-15 | ||
PCT/GB2001/002120 WO2001087895A1 (en) | 1999-05-14 | 2001-05-15 | Synthetic process for the manufacture of an ecteinaschidin compound |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2003533533A JP2003533533A (en) | 2003-11-11 |
JP2003533533A5 true JP2003533533A5 (en) | 2008-07-03 |
JP4942900B2 JP4942900B2 (en) | 2012-05-30 |
Family
ID=29595488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001584289A Expired - Lifetime JP4942900B2 (en) | 2000-05-15 | 2001-05-15 | Synthetic methods for the production of echinasaidin compounds |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP4942900B2 (en) |
IL (1) | IL152125A (en) |
NZ (1) | NZ521808A (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5721362A (en) * | 1996-09-18 | 1998-02-24 | President And Fellows Of Harvard College | Process for producing ecteinascidin compounds |
MY130271A (en) * | 1999-05-14 | 2007-06-29 | Pharma Mar Sa | Hemisynthetic method and new compounds |
-
2001
- 2001-05-15 IL IL152125A patent/IL152125A/en active IP Right Grant
- 2001-05-15 JP JP2001584289A patent/JP4942900B2/en not_active Expired - Lifetime
- 2001-05-15 NZ NZ521808A patent/NZ521808A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69719098T2 (en) | METHOD FOR PRODUCING CITALOPRAM | |
US20060199958A1 (en) | Process and intermediates for the preparation of pyrrolidine carboxylic acids | |
JP2001519410A5 (en) | ||
IL222041A (en) | Method for preparing optionally substituted 2-cyclopropyl and 2-phenyl 1,6-dihydro-6-oxo-4-pyrimidine carboxylic acids and intermediates | |
CN1035823A (en) | 1, the 4-Disubstituted-piperidnyl compounds | |
JP2004504403A5 (en) | ||
EP2289888A3 (en) | Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them | |
WO1999021830A1 (en) | Process for stereoselective synthesis of prostacyclin derivatives | |
PL368722A1 (en) | Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide | |
JP2005514459A (en) | Method for producing phenserine and its analogs | |
JP2003533533A5 (en) | ||
JP2005502603A5 (en) | ||
CN1105996A (en) | Preparation of imidazopyridine derivative | |
JP4294121B2 (en) | Process for producing pyridonecarboxylic acid derivatives and intermediates thereof | |
JP2001233852A5 (en) | ||
Achmatowicz et al. | The synthesis of l-proline derived tetraazamacrocyclic ligands of C2 symmetry via intramolecular ester aminolysis | |
JPH11507059A (en) | Stereoselective method for synthesizing dorafenin | |
US5821369A (en) | Racemisation process | |
WO2002012184A1 (en) | Process for preparing alpha-amino acids and their derivatives including phenylalanine and homophenylalanine and their intermediates | |
WO1999014184A1 (en) | Novel stereoselective processes for the preparation of gabapentin analogues | |
JP2004503519A5 (en) | ||
JP4491074B2 (en) | Stereoselective process for producing nitroenamine compounds | |
CN1173915C (en) | The preparation method of 1,4-dicarbonyl compound | |
JP4529419B2 (en) | Optically active fluorine-containing compounds and methods for producing them | |
EP1204636A1 (en) | 3-oxopropane-1-sulphonic acids and sulphonates |